Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Trop Anim Health Prod ; 47(8): 1481-6, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26210396

ABSTRACT

The legume Leucaena leucocephala (Leucaena) is widely used to supplement forage in silvopastoral livestock systems in Latin America. Little is known about its possible effects on the cow reproductive dynamic. The aim was to evaluate the effect of Leucaena foliage intake on re-establishment of ovarian activity and estrus behavior in early postpartum (7-90 days) cows. Twenty-four multiparous Bos taurus × Bos indicus cows were divided into two homogenous groups and assigned to one of two treatments: a silvopastoral system (SS, n = 12), consisting of an association of Cynodon nlemfuensis grass and L. leucocephala; and a control system (CS, n = 12), consisting of C. nlemfuensis alone. Intake of Leucaena in the SS ranged from 3.80 to 6.43 kg DM/cow/day. Plasma mimosine concentrations ranged from 1270 to 1530 µg/mL, and those for 2,3-dihydroxypyridine (DHP) from 147 to 729 µg/mL. No 3,4-DHP was detected in plasma. No difference (P > 0.05) between treatments was observed for the number of cows exhibiting small, medium, or dominant follicles, or estrus behavior. The number of cows which re-established ovarian cyclicity (n = 6) was lower (P < 0.05) in the SS than in the CS (n = 9). Corpus luteum lifespan was longer (P < 0.05) in the SS than in the CS. Intake of Leucaena affected the number of cows exhibiting ovarian cyclicity and extended corpus luteum life, but did not affect follicular development and estrus behavior.


Subject(s)
Corpus Luteum/drug effects , Estrous Cycle/drug effects , Fabaceae , Mimosine/adverse effects , Reproduction , Animal Feed/adverse effects , Animal Feed/statistics & numerical data , Animals , Blood Urea Nitrogen , Cattle , Diet/veterinary , Dietary Supplements , Estrus , Female , Ovary/drug effects , Parity , Postpartum Period
2.
Int Immunopharmacol ; 27(1): 53-64, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25957199

ABSTRACT

It has also been shown that the decreased expression of eukaryotic translation initiation factor 3a (eIF3a) by L-mimosine caused cell cycle arrest. Our previous study has found that eIF3a is involved in bleomycin-induced pulmonary fibrosis. Whether the eIF3a/p27 signal pathway is involved in the inhibitory effect of L-mimosine on bleomycin-induced pulmonary fibrosis remains unknown. Pulmonary fibrosis was induced by intratracheal instillation of bleomycin (5 mg/kg) in rats. Primary pulmonary fibroblasts were cultured to investigate the proliferation by BrdU incorporation method and flow cytometry. The expression of eIF3a, p27, α-SMA, collagen I and collagen III was analyzed by qPCR and Western blot. In vivo, L-mimosine treatment significantly ameliorated the bleomycin-mediated histological fibrosis alterations and blocked collagen deposition concomitantly with reversing bleomycin-induced expression up-regulation of eIF3a, α-SMA, collagen I and collagen III (both mRNA and protein) and expression down- regulation of p27. In vitro, L-mimosine remarkably attenuated proliferation of pulmonary fibroblasts and expression of α-SMA, collagen I and collagen III induced by TGF-ß1, and this inhibitory effect of L-mimosine was accompanied by inhibiting eIF3a expression and increasing p27 expression. Knockdown of eIF3a gene expression reversed TGF-ß1-induced proliferation of fibroblasts, down-regulation of p27 expression and up-regulation of α-SMA, collagen I, and collagen III expression. These results suggest that L-mimosine inhibited the progression of bleomycin-induced pulmonary fibrosis in rats via the eIF3a/p27 pathway.


Subject(s)
Eukaryotic Initiation Factor-3/metabolism , Fibroblasts/drug effects , Lung/pathology , Mimosine/administration & dosage , Pulmonary Fibrosis/drug therapy , Actins/genetics , Actins/metabolism , Animals , Bleomycin/administration & dosage , Cell Proliferation/drug effects , Cells, Cultured , Collagen/metabolism , Cyclin-Dependent Kinase Inhibitor p27/genetics , Cyclin-Dependent Kinase Inhibitor p27/metabolism , Eukaryotic Initiation Factor-3/genetics , Fibroblasts/physiology , Gene Expression Regulation/drug effects , Humans , Male , Mimosine/adverse effects , Pulmonary Fibrosis/chemically induced , RNA, Small Interfering/genetics , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Transforming Growth Factor beta/metabolism
3.
Mol Nutr Food Res ; 55(11): 1666-76, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21936051

ABSTRACT

SCOPE: Prostate-specific antigen (PSA) is a well-known marker for diagnosing and monitoring prostate cancer. Curcumin, a yellow curry pigment, has been reported to enhance androgen receptor (AR) degradation. We examined the effects of curcumin on increasing PSA expression by hypoxia and prolyl hydroxylase inhibitors, L-mimosine and dimethyloxalylglycine (DMOG), in human prostate carcinoma LNCaP cells. METHODS AND RESULTS: The 3H-thymidine incorporation assay revealed that either L-mimosine or DMOG treatments attenuated cell proliferation. Immunoblot and enzyme-linked immunosorbent assays (ELISA) indicated that both L-mimosine and DMOG have an effect similar to hypoxia, which stabilized hypoxia-inducible factor-1α (HIF-1α) and induced PSA gene expression. The results of the immunoblot and transient gene expression assays indicated that induction of the PSA expression by hypoxia is both HIF-1α- and AR-dependent. Immunoblot assays revealed that a curcumin treatment (10 µM) decreased the protein abundance of AR but did not significantly affect the protein levels of HIF-1α and vascular endothelial growth factor, which were induced by hypoxia. ELISA and transient gene expression assays indicated that curcumin blocked the activation of L-mimosine or DMOG treatment on PSA expression. CONCLUSIONS: These results indicate that curcumin blocked the enhanced effect of PSA expression by L-mimosine and DMOG that induce hypoxia condition.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Carcinoma/drug therapy , Cell Hypoxia/drug effects , Curcumin/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Prostate-Specific Antigen/metabolism , Prostatic Neoplasms/drug therapy , Amino Acids, Dicarboxylic/adverse effects , Amino Acids, Dicarboxylic/antagonists & inhibitors , Amino Acids, Dicarboxylic/pharmacology , Antineoplastic Agents/adverse effects , Antineoplastic Agents/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Carcinoma/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Inhibitors/pharmacology , Genes, Reporter/drug effects , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Iron Chelating Agents/adverse effects , Iron Chelating Agents/chemistry , Iron Chelating Agents/pharmacology , Male , Mimosine/adverse effects , Mimosine/antagonists & inhibitors , Mimosine/pharmacology , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/metabolism , Procollagen-Proline Dioxygenase/antagonists & inhibitors , Prostate-Specific Antigen/genetics , Prostatic Neoplasms/metabolism , Recombinant Proteins/metabolism
4.
Am J Primatol ; 71(3): 199-205, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19051314

ABSTRACT

Fur condition in wild ringtailed lemurs, Lemur catta, was recorded during September-November birth seasons 2001-2006 at Berenty Reserve, Madagascar. Body coat condition was scored on a scale from BS 0: full, smooth coat with guard hairs, to BS5: half or more of back and limbs hairless. Tail condition was scored from TS 0: full, to TS 5: half or more hairless. Where troop core areas included stands of Leucaena leucocephala, alopecia was dramatically more frequent than in similar areas without leucaena, including many animals with score BS5 or TS5, "bald lemur syndrome." Females' coats were worse than males', possibly related to female dominance and access to this preferred food. Tails in non-leucaena-feeding females tend to remain full, even if coats deteriorate, but with leucaena-feeding female tails are highly correlated with coat condition and equally bare. Coat and tail condition in L. catta reflected not only the dietary toxin but individual differences as well as differences between adjacent troops that may result from territorially mediated access to the environment. Leucaena contains the non-protein amino acid mimosine, a known cause of alopecia, wasting, and organ damage in livestock, although the effects are usually reversible. This is the first case of its effect in wildlife. Leucaena is an agroforestry tree introduced throughout the tropics. In high dietary concentrations leucaena might potentially affect any browsing mammal.


Subject(s)
Alopecia/veterinary , Fabaceae/chemistry , Hair/physiopathology , Lemur , Mimosine/adverse effects , Tail , Alopecia/chemically induced , Alopecia/physiopathology , Animals , Diet , Environment , Fabaceae/growth & development , Female , Health Status Indicators , Madagascar , Male , Sex Factors
5.
Aust J Biol Sci ; 28(1): 69-84, 1975 Feb.
Article in English | MEDLINE | ID: mdl-1167194

ABSTRACT

Twenty-two Merino sheep were dosed with various amounts of L-mimosine, given either as an intravenous or an intraperitoneal injection, or as a continuous intravenous infusion for periods of 1-4 days. Single injections of mimosine (1-16 g) had no effect on the strength of wool, and wool growth rates were not appreciably altered by injections of small amounts (4 g or less). Injections of larger amounts slightly reduced both length growth rate and diameter of tibres during the 4 days after dosing. The effects of intravenous infusions of mimosine depended on the rate and the duration of administration. Small amounts (0.5 or 1 g/day given for 4 days) has no effects on the strength of wool or on wool growth rates. Infusions of a total of 8 g, either at the rate of 2 or 8 g/day, weakened the wool but not sufficiently to allow the sheep to be defleeced. Both these treatments caused a temporary reduction in length growth rate and in diameter of fibres, and transient degenerative changes were observed in wool follicles. A region of the fibres representing 1-2 days' growth was constricted to about half the pre-infusion diameter when 8 g was given for 1 day. Infusions of at least 8 g mimosine over a period of 1 1/2-2 days were effective for defleecing all sheep dosed. This corresponded to a daily rate of infusion of about 80 mg/kg. No toxic effects were observed with infusions given for periods of 2 days. Defleecing was judged to be possible by 6-7 days after the start of infusion, and was readily carried out by about 14 days. Defleecing was associated with follicle retrogression and an abrupt cessation of wool growth within 2 days of the start of the infusions. It was estimated that fibre growth stopped for about 10 dyas; regrowth was first observed 17-18 days from the beginning of dosing. Low rates of infusion of mimosine (up to 2 g/day) resulted in plasma levels below 0.1 mmol/l. Infusion at the rate of 4 g/day or above, which produced defleecing, quickly resulted in levels of mimosine in plasma above 0.1 mmol/l; after 2 days the concentration was steady at aboug 0.2 mmol/l. Injections of 8 or 16 g mimosine resulted in very large, but transient, rises of the level in plasma.


Subject(s)
Mimosine/pharmacology , Pyridones/pharmacology , Sheep , Skin/drug effects , Wool/drug effects , Animals , Depression, Chemical , Male , Mimosine/adverse effects , Mimosine/blood , Sheep/blood , Wool/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...